Eagle Pharmaceuticals Reports Third Quarter 2020 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Eagle Pharmaceuticals Reports Third Quarter 2020 Results

Eagle Pharmaceuticals (EGRX) Tops Q3 EPS by 89c

November 2, 2020 6:49 AM EST

Eagle Pharmaceuticals (NASDAQ: EGRX) reported Q3 EPS of $1.17, $0.89 better than the analyst estimate of $0.28. Revenue for the quarter came in at $49.9 million versus the consensus estimate of $47.02 million.

2020 Expense Guidance:

R&D expense in 2020, on a non-GAAP... More